Chidamide plus prednisone, cyclophosphamide, and thalidomide for relapsed or refractory peripheral T-cell lymphoma: A multicenter phase II trial by Jinhua Liang, Li Wang, Xiaodong Wang, Guohui Cui, Jianfeng Zhou, Tongyao Xing, Kaixin Du, Jingyan Xu, Luqun Wang, Rong Liang, Biyun Chen, Jian Cheng, Haorui Shen, Jianyong Li, Wei Xu, Ting Gao, Xiuyuan Hao

Get full text